Supply Chain

The Food and Drug Adminstration on Wednesday granted market clearance to OptiScan Biomedical Corp.'s OptiScanner 5000 Glucose Monitoring System for use in the surgical intensive care unit.

Drug companies produce eye drops at a size much larger than the human eye can hold, reports ProPublica.

The Food and Drug Administration on Monday granted market clearance to Stryker's cementless knee implant.

Amneal Pharmaceuticals and Impax Laboratories will combine to form the fifth largest generics business in the country, based on revenue.

The United Kingdom and European Union have yet to reach a trade deal for medications ahead of Britain's 2019 exit from the EU, according to Bloomberg.

Michael Laufer, PhD, a college professor and leader in the growing biohacker movement, wants to teach patients how to make their own medications to subvert the drug industry's high prices, according to STAT.

Here are six drug and medical device companies that made headlines in the past week.

Roche formed a strategic collaboration with the drug discovery company Warp Drive Bio to develop new classes of antibiotics.

The Food and Drug Administration on Friday expanded the approval for Johnson & Johnson's psoriasis drug Stelara.

The FDA approved a new robotically- assisted surgical device, Senhance System, to facilitate minimally invasive surgeries.